Intellia Therapeutics (NTLA) Preferred Shares Issued (2015)
Intellia Therapeutics (NTLA) reported Preferred Shares Issued of $70.0 million for Q3 2015, up 1407.69% quarter-over-quarter from $4.6 million in Q1 2015.
Intellia Therapeutics (NTLA) Preferred Shares Issued (2015) Analysis & Trends
Intellia Therapeutics (NTLA) has 1 years of Preferred Shares Issued data on file, last reported at $70.0 million in Q3 2015.
- Preferred Shares Issued for Q3 2015 came in at $70.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2015 was $74.7 million (changed N/A YoY), and the FY2015 annual result was $74.7 million, up 490.16% from the prior year.
- Preferred Shares Issued improved to $70.0 million in Q3 2015 per NTLA's latest filing, from $4.6 million in the prior quarter.
- Over five years, Preferred Shares Issued peaked at $70.0 million in Q3 2015 and troughed at $4.6 million in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Intellia Therapeutics | 1.86 Bn | 1.86 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 70.02 Mn |
| Sep 30, 2015 | 70.02 Mn |
| Mar 31, 2015 | 4.64 Mn |
| Mar 31, 2015 | 4.64 Mn |